GBA's "2021 Stock Phantasma"

Discussion in 'Stocks' started by stonedinvestor, Jan 1, 2021.

  1. vanzandt

    vanzandt

    Seeeee. You never read my posts. That's why I have to bash your stocks, to get you to pay attention.

     
    #6671     Jul 13, 2021
  2. vanzandt

    vanzandt

    Right on schedule.
     
    #6672     Jul 13, 2021
  3. Verve Therapeutics, Inc. (VERV)

    54.34+6.13 (+12.73%)<------
    As of 10:33AM EDT.
     
    #6673     Jul 13, 2021

  4. No I read it but the name of the Japanese company! That I found.
    IHI Corporation (IHICY) Seems to trade in 1 hr movements
    Other OTC - Other OTC Delayed Price. Currency in USD

    $5.650.00 (0.00%)
    As of July 7 9:40AM
     
    #6674     Jul 13, 2021
  5.  
    #6675     Jul 13, 2021
  6. The Next Frontier in Bio is probably psychedelic -

    Psychedelic drug developers started as buys
    • Citi, Credit Suisse, Canaccord Genuity, and Cantor Fitzgerald have initiated Atai Life Sciences (ATAI +2.3%) with buy/overweight ratings.
    • Credit Suisse has a $25 price target on shares (~35% upside)
    • Credit Suisse analyst Judah Frommer says the company has developed 10 development programs and six enabling technologies covering areas such as depression, anxiety, and post-traumatic stress disorder. Five of those programs center around psychedelic compounds.
    • Although development of psychedelics for mental health conditions is in its infancy, "we believe significant unmet need could drive a paradigm shift in how mental health disorders are treated in the next ~10 years," he says.
    • Citi's Neena Bitritto-Garg writes that emerging data on the clinical benefit of psychedelics and increasing regulatory flexibility is a boon to companies like Atai.
    • Citi surveyed 108 psychiatrists and most said they would be eager to prescribe psychedelic prescription medications in a meaningful way.
    • Bitritto-Garg also initiated psychedelics player COMPASS Pathways (CMPS +2.4%) with a buy.
    ATAI--
     
    #6676     Jul 13, 2021
  7. ATAI
    Atai Life Sciences
    $20.04
    +1.25 (+6.65%)
     
    #6677     Jul 13, 2021
  8. vanzandt

    vanzandt

    What do you think about AZEK down here at $38?
    It's at that H&S cusp on a 1 year chart.
    Earnings should be the 2nd week of August, but they have not given out a date yet, I don't think.

    CEO has been selling shares.
    That's bs imo.
    He gets on Cramer and says what a great company it is.
    Then why sell your shares?
    Your salary is quite adequate to have a 3 million dollar plus estate and a few toys...
     
    #6678     Jul 13, 2021
  9. RBLX MIGHT BE A BUY AT $82.

    Roblox Corporation (RBLX)
    $83.23-3.31 (-3.83%)
     
    #6679     Jul 13, 2021
  10. Yea AZEK CEO is a putz. The future is great I'm selling.

    These guys are a few bucks beneath a secondary they did I believe at $43.50!

    Those folks got lied to. And then he sold. They cannot be happy. So when this gets back to $43.50 they just say bye bye. This stock is now in WEAK HANDS,,,

    I still think Weak Hands/Strong Hands is a great idea for a thread and an investing style.
     
    #6680     Jul 13, 2021